While some mutations outside the RBD site were found to escape antibody binding [55], all six of our potent antibodies retained high binding signals when tested with S protein variants harboring some of the most common mutations on the GISAD sequencing database for COVID-19 on December, 2020 (S10A Fig). This evidence concerns the gene PROS1 and COVID-19.